View in EDS

660P Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update.

Saved in:
Bibliographic Details
Title: 660P Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update.
Authors: Choueiri, T.K.1 (AUTHOR), Eto, M.2 (AUTHOR), Kopyltsov, E.3 (AUTHOR), Rha, S.Y.4 (AUTHOR), Porta, C.G.5 (AUTHOR), Motzer, R.6 (AUTHOR), Grünwald, V.7 (AUTHOR), Hutson, T.E.8 (AUTHOR), Méndez-Vidal, M.J.9 (AUTHOR), Hong, S-H.10 (AUTHOR), Winquist, E.11 (AUTHOR), Goh, J.C.H.12 (AUTHOR), Maroto, P.13 (AUTHOR), Buchler, T.14 (AUTHOR), Takagi, T.15 (AUTHOR), Rodriguez-Lopez, K.16 (AUTHOR), Xing, D.17 (AUTHOR), Smith, A.D.18 (AUTHOR), Powles, T.19 (AUTHOR)
Source: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS683-S685. 3p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 152688405
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 660P Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Choueiri%2C+T%2EK%2E%22">Choueiri, T.K.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eto%2C+M%2E%22">Eto, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kopyltsov%2C+E%2E%22">Kopyltsov, E.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rha%2C+S%2EY%2E%22">Rha, S.Y.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Porta%2C+C%2EG%2E%22">Porta, C.G.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Motzer%2C+R%2E%22">Motzer, R.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grünwald%2C+V%2E%22">Grünwald, V.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hutson%2C+T%2EE%2E%22">Hutson, T.E.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Méndez-Vidal%2C+M%2EJ%2E%22">Méndez-Vidal, M.J.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hong%2C+S-H%2E%22">Hong, S-H.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Winquist%2C+E%2E%22">Winquist, E.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goh%2C+J%2EC%2EH%2E%22">Goh, J.C.H.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maroto%2C+P%2E%22">Maroto, P.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Buchler%2C+T%2E%22">Buchler, T.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Takagi%2C+T%2E%22">Takagi, T.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rodriguez-Lopez%2C+K%2E%22">Rodriguez-Lopez, K.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xing%2C+D%2E%22">Xing, D.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Smith%2C+A%2ED%2E%22">Smith, A.D.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Powles%2C+T%2E%22">Powles, T.</searchLink><relatesTo>19</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2021 Supplement 5, Vol. 32, pS683-S685. 3p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152688405
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2021.08.056
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 3
        StartPage: S683
    Titles:
      – TitleFull: 660P Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Choueiri, T.K.
      – PersonEntity:
          Name:
            NameFull: Eto, M.
      – PersonEntity:
          Name:
            NameFull: Kopyltsov, E.
      – PersonEntity:
          Name:
            NameFull: Rha, S.Y.
      – PersonEntity:
          Name:
            NameFull: Porta, C.G.
      – PersonEntity:
          Name:
            NameFull: Motzer, R.
      – PersonEntity:
          Name:
            NameFull: Grünwald, V.
      – PersonEntity:
          Name:
            NameFull: Hutson, T.E.
      – PersonEntity:
          Name:
            NameFull: Méndez-Vidal, M.J.
      – PersonEntity:
          Name:
            NameFull: Hong, S-H.
      – PersonEntity:
          Name:
            NameFull: Winquist, E.
      – PersonEntity:
          Name:
            NameFull: Goh, J.C.H.
      – PersonEntity:
          Name:
            NameFull: Maroto, P.
      – PersonEntity:
          Name:
            NameFull: Buchler, T.
      – PersonEntity:
          Name:
            NameFull: Takagi, T.
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Lopez, K.
      – PersonEntity:
          Name:
            NameFull: Xing, D.
      – PersonEntity:
          Name:
            NameFull: Smith, A.D.
      – PersonEntity:
          Name:
            NameFull: Powles, T.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2021 Supplement 5
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 32
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1